198 related articles for article (PubMed ID: 18703255)
1. A comparative study to screen dementia and APOE genotypes in an ageing East African population.
Chen CH; Mizuno T; Elston R; Kariuki MM; Hall K; Unverzagt F; Hendrie H; Gatere S; Kioy P; Patel NB; Friedland RP; Kalaria RN
Neurobiol Aging; 2010 May; 31(5):732-40. PubMed ID: 18703255
[TBL] [Abstract][Full Text] [Related]
2. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E polymorphism in elderly east Africans.
Sayi JG; Patel NB; Premkumar DR; Adem A; Winblad B; Matuja WB; Mtui EP; Gatere S; Friedland RP; Koss E; Kalaria RN
East Afr Med J; 1997 Oct; 74(10):668-70. PubMed ID: 9529753
[TBL] [Abstract][Full Text] [Related]
4. APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.
Hendrie HC; Murrell J; Baiyewu O; Lane KA; Purnell C; Ogunniyi A; Unverzagt FW; Hall K; Callahan CM; Saykin AJ; Gureje O; Hake A; Foroud T; Gao S
Int Psychogeriatr; 2014 Jun; 26(6):977-85. PubMed ID: 24565289
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
Yip AG; Brayne C; Easton D; Rubinsztein DC;
J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
[TBL] [Abstract][Full Text] [Related]
6. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.
Osuntokun BO; Sahota A; Ogunniyi AO; Gureje O; Baiyewu O; Adeyinka A; Oluwole SO; Komolafe O; Hall KS; Unverzagt FW
Ann Neurol; 1995 Sep; 38(3):463-5. PubMed ID: 7668835
[TBL] [Abstract][Full Text] [Related]
7. [Apolipoprotein E genotypes in patients investigated for dementia].
Johannsen P; Jakobsen JK; Jørgensen AL
Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease, genes, and environment: the value of international studies.
Hendrie HC; Hall KS; Ogunniyi A; Gao S
Can J Psychiatry; 2004 Feb; 49(2):92-9. PubMed ID: 15065742
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans.
Hendrie HC; Hall KS; Hui S; Unverzagt FW; Yu CE; Lahiri DK; Sahota A; Farlow M; Musick B; Class CA
Ann Neurol; 1995 Jan; 37(1):118-20. PubMed ID: 7818244
[TBL] [Abstract][Full Text] [Related]
11. Association of the epsilon 4 allele of apolipoprotein E with poor performance on a dementia screen in African Americans.
Hui SL; Gao S; Hall KS; Sahota A; Hendrie HC
Ethn Dis; 1996; 6(3-4):266-71. PubMed ID: 9086316
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.
Hall K; Murrell J; Ogunniyi A; Deeg M; Baiyewu O; Gao S; Gureje O; Dickens J; Evans R; Smith-Gamble V; Unverzagt FW; Shen J; Hendrie H
Neurology; 2006 Jan; 66(2):223-7. PubMed ID: 16434658
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients.
Scacchi R; De Bernardini L; Mantuano E; Donini LM; Vilardo T; Corbo RM
Neurosci Lett; 1995 Dec; 201(3):231-4. PubMed ID: 8786847
[TBL] [Abstract][Full Text] [Related]
14. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana.
Hendrie HC; Ogunniyi A; Hall KS; Baiyewu O; Unverzagt FW; Gureje O; Gao S; Evans RM; Ogunseyinde AO; Adeyinka AO; Musick B; Hui SL
JAMA; 2001 Feb; 285(6):739-47. PubMed ID: 11176911
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.
Lasser RA; Dukoff R; Levy J; Levin R; Lehtimäki T; Seubert P; Sunderland T
Int J Geriatr Psychiatry; 1998 Nov; 13(11):767-74. PubMed ID: 9850873
[TBL] [Abstract][Full Text] [Related]
16. Cognitive change and the APOE epsilon 4 allele.
Deary IJ; Whiteman MC; Pattie A; Starr JM; Hayward C; Wright AF; Carothers A; Whalley LJ
Nature; 2002 Aug; 418(6901):932. PubMed ID: 12198535
[TBL] [Abstract][Full Text] [Related]
17. Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia.
Katzman R; Zhang MY; Chen PJ; Gu N; Jiang S; Saitoh T; Chen X; Klauber M; Thomas RG; Liu WT; Yu ES
Neurology; 1997 Sep; 49(3):779-85. PubMed ID: 9305340
[TBL] [Abstract][Full Text] [Related]
18. Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study.
Molero AE; Pino-Ramírez G; Maestre GE
Neurosci Lett; 2001 Jul; 307(1):5-8. PubMed ID: 11516561
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.
Brayne C; Harrington CR; Wischik CM; Huppert FA; Chi LY; Xuereb JH; O'Connor DW; Paykel ES
Dementia; 1996; 7(3):169-74. PubMed ID: 8740632
[TBL] [Abstract][Full Text] [Related]
20. Olfactory function in people with genetic risk of dementia.
Salerno-Kennedy R; Cusack S; Cashman KD
Ir J Med Sci; 2005; 174(4):46-50. PubMed ID: 16445161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
